{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:03:31Z","timestamp":1790129011106,"version":"4.0.1"},"reference-count":77,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007526","name":"Universit\u00e9 de Tours","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007526","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009469","name":"R\u00e9gion Centre-Val de Loire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009469","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006510","name":"ARSLA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.neurot.2026.e01032","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T14:32:50Z","timestamp":1786026770000},"page":"e01032","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intrabody B1 targeting TDP-43 modulates neuroinflammatory and metabolic pathways in a preclinical ALS model"],"prefix":"10.1016","volume":"23","author":[{"given":"Y.","family":"Al Ojaimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Dupuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Palla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Lanznaster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Hergesheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Galineau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Serriere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.A.","family":"Chami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Martineau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Alouane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Marouillat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Dupuy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.L.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Veyrat-Durebex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Masse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Trovero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.R.","family":"Andres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Corcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Vourc\u02bch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Blasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurot.2026.e01032_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1401706","article-title":"Advancements and challenges in amyotrophic lateral sclerosis","volume":"18","author":"Bradford","year":"2024","journal-title":"Front Neurosci"},{"key":"10.1016\/j.neurot.2026.e01032_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/cells14100715","article-title":"Current challenges in elucidating ALS disease mechanisms and therapeutic advances","volume":"14","author":"Saxena","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.neurot.2026.e01032_bib3","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1039\/D1CB00110H","article-title":"Direct targeting of TDP-43, from small molecules to biologics: the therapeutic landscape","volume":"2","author":"Francois-Moutal","year":"2021","journal-title":"RSC Chem Biol"},{"key":"10.1016\/j.neurot.2026.e01032_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0322021","article-title":"scFv intrabody targeting wildtype TDP-43 presents protective effects in a cellular model of TDP-43 proteinopathy","volume":"20","author":"Al Ojaimi","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.neurot.2026.e01032_bib5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12974-025-03658-2","article-title":"Neuronal TDP-43 pathology drives astrocytic interferon response in a mouse model of ALS","volume":"23","author":"An","year":"2025","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.neurot.2026.e01032_bib6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41419-026-08437-2","article-title":"Mutant TDP-43 drives impairments in axonal transport and glycolysis in a mouse stem-cell-derived motor neuron model of amyotrophic lateral sclerosis (ALS)","volume":"17","author":"Carroll","year":"2026","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.neurot.2026.e01032_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.conb.2025.103163","article-title":"ALS-related proteinopathies: from TDP-43 to mitochondrial proteinopathies","volume":"97","author":"Genin","year":"2026","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.neurot.2026.e01032_bib8","article-title":"Pleiotrophin\/midkine pathway is dysregulated in a TDP-43A315T mouse model of amyotrophic lateral sclerosis (ALS)","volume":"46","author":"Mart\u00ednez-Ales\u00f3n","year":"2026","journal-title":"Neuropathol Off J Jpn Soc Neuropathol"},{"key":"10.1016\/j.neurot.2026.e01032_bib9","doi-asserted-by":"crossref","first-page":"115138","DOI":"10.1016\/j.expneurol.2025.115138","article-title":"Virus-mediated delivery of single-chain antibody targeting TDP-43 protects against neuropathology, cognitive impairment and motor deficit caused by chronic cerebral hypoperfusion","volume":"385","author":"Chami","year":"2025","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neurot.2026.e01032_bib10","doi-asserted-by":"crossref","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","article-title":"Fastp: an ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.neurot.2026.e01032_bib11","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","article-title":"MultiQC: summarize analysis results for multiple tools and samples in a single report","volume":"32","author":"Ewels","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.neurot.2026.e01032_bib12","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.12688\/f1000research.15931.1","article-title":"FastQ screen: a tool for multi-genome mapping and quality control","volume":"7","author":"Wingett","year":"2018","journal-title":"F1000Research"},{"key":"10.1016\/j.neurot.2026.e01032_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.neurot.2026.e01032_bib14","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.neurot.2026.e01032_bib15","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3390\/metabo11100681","article-title":"Analytical methodology for a metabolome atlas of goat\u2019s plasma, milk and feces using 1H-NMR and UHPLC-HRMS","volume":"11","author":"Martias","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.neurot.2026.e01032_bib16","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1101\/gad.194829.112","article-title":"Autoregulation of TDP-43 mRNA levels involves interplay between transcription, splicing, and alternative polyA site selection","volume":"26","author":"Avenda\u00f1o-V\u00e1zquez","year":"2012","journal-title":"Genes Dev"},{"key":"10.1016\/j.neurot.2026.e01032_bib17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41583-021-00431-1","article-title":"Triad of TDP43 control in neurodegeneration: autoregulation, localization and aggregation","volume":"22","author":"Tziortzouda","year":"2021","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.neurot.2026.e01032_bib18","doi-asserted-by":"crossref","first-page":"104514","DOI":"10.1016\/j.nbd.2019.104514","article-title":"TDP-43 knockdown causes innate immune activation via protein kinase R in astrocytes","volume":"132","author":"LaRocca","year":"2019","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neurot.2026.e01032_bib19","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1084\/jem.20111313","article-title":"Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor \u03baB\u2013mediated pathogenic pathways","volume":"208","author":"Swarup","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.neurot.2026.e01032_bib20","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s12974-018-1350-y","article-title":"Age-related deregulation of TDP-43 after stroke enhances NF-\u03baB-mediated inflammation and neuronal damage","volume":"15","author":"Thammisetty","year":"2018","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.neurot.2026.e01032_bib21","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1172\/JCI123931","article-title":"Virus-mediated delivery of antibody targeting TAR DNA-binding protein-43 mitigates associated neuropathology","volume":"129","author":"Pozzi","year":"2019","journal-title":"J Clin Investig"},{"key":"10.1016\/j.neurot.2026.e01032_bib22","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cell.2010.03.040","article-title":"NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways","volume":"141","author":"Cui","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.neurot.2026.e01032_bib23","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/cr.2012.53","article-title":"Enhanced TLR-induced NF-\u03baB signaling and type I interferon responses in NLRC5 deficient mice","volume":"22","author":"Tong","year":"2012","journal-title":"Cell Res"},{"key":"10.1016\/j.neurot.2026.e01032_bib24","doi-asserted-by":"crossref","first-page":"19796","DOI":"10.1038\/s41598-024-67165-9","article-title":"Inflammatory signature in amyotrophic lateral sclerosis predicting disease progression","volume":"14","author":"Femiano","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.neurot.2026.e01032_bib25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.tins.2020.10.003","article-title":"Neuroprotective versus neuroinflammatory roles of complement: from development to disease","volume":"44","author":"Kanmogne","year":"2021","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neurot.2026.e01032_bib26","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.2147\/JIR.S298307","article-title":"Complement profiles in patients with amyotrophic lateral sclerosis: a prospective observational cohort study","volume":"14","author":"Kj\u00e6ldgaard","year":"2021","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.neurot.2026.e01032_bib27","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2174\/1567205013666161013091934","article-title":"Complement C4A and C4B gene copy number study in alzheimer\u2019s disease patients","volume":"14","author":"Zorzetto","year":"2017","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.neurot.2026.e01032_bib28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s13105-023-00989-7","article-title":"Silencing suppressor of cytokine signaling 3 induces apoptosis and activates the p-STAT3\/NF-\u03baB pathway in hypoxic cultivated H9c2 cells","volume":"80","author":"Gu","year":"2024","journal-title":"J Physiol Biochem"},{"key":"10.1016\/j.neurot.2026.e01032_bib29","first-page":"151","article-title":"SOCS3 control the activity of NF-\u03baB induced by HSP70 via degradation of MyD88-adapter-like protein (mal) in IPEC-J2 cells","volume":"36","author":"Yong","year":"2019","journal-title":"Int J Hyperth Off J Eur Soc Hyperthermic Oncol North Am Hyperth Group"},{"key":"10.1016\/j.neurot.2026.e01032_bib30","doi-asserted-by":"crossref","first-page":"586905","DOI":"10.3389\/fneur.2020.586905","article-title":"Reducing suppressors of cytokine Signaling-3 (SOCS3) expression promotes M2 macrophage polarization and functional recovery after intracerebral hemorrhage","volume":"11","author":"Ji","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.neurot.2026.e01032_bib31","doi-asserted-by":"crossref","first-page":"14090","DOI":"10.1128\/JVI.01346-14","article-title":"Suppressors of cytokine signaling 1 and 3 are upregulated in brain resident cells in response to virus-induced inflammation of the central nervous system via at least two distinctive pathways","volume":"88","author":"Steffensen","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.neurot.2026.e01032_bib32","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.07.001","article-title":"Stressing out over tRNA cleavage","volume":"138","author":"Thompson","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.neurot.2026.e01032_bib33","doi-asserted-by":"crossref","first-page":"7923","DOI":"10.3390\/ijms21217923","article-title":"Heterogeneity of neuroinflammatory responses in amyotrophic lateral sclerosis: a challenge or an opportunity?","volume":"21","author":"Cipollina","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurot.2026.e01032_bib34","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1007\/s00259-022-05719-7","article-title":"[18F]DPA-714 PET imaging for the quantitative evaluation of early spatiotemporal changes of neuroinflammation in rat brain following status epilepticus","volume":"49","author":"Kaneko","year":"2022","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.neurot.2026.e01032_bib35","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s40142-017-0123-8","article-title":"Metabolic dysregulation in amyotrophic lateral sclerosis: challenges and opportunities","volume":"5","author":"Joardar","year":"2017","journal-title":"Curr Genet Med Rep"},{"key":"10.1016\/j.neurot.2026.e01032_bib36","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3390\/biom13050863","article-title":"Evidence of metabolic dysfunction in amyotrophic lateral sclerosis (ALS) patients and animal models","volume":"13","author":"Maksimovic","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.neurot.2026.e01032_bib37","doi-asserted-by":"crossref","first-page":"588","DOI":"10.2174\/1871527322666230330083757","article-title":"Acetyl-L-carnitine and amyotrophic lateral sclerosis: current evidence and potential use","volume":"23","author":"De Marchi","year":"2024","journal-title":"CNS Neurol Disord: Drug Targets"},{"key":"10.1016\/j.neurot.2026.e01032_bib38","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.3390\/genes14111981","article-title":"Mitochondria, a key target in amyotrophic lateral sclerosis pathogenesis","volume":"14","author":"Genin","year":"2023","journal-title":"Genes"},{"key":"10.1016\/j.neurot.2026.e01032_bib39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ana.27208","article-title":"Longitudinal metabolomics in amyotrophic lateral sclerosis implicates impaired lipid metabolism","volume":"98","author":"Guo","year":"2025","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurot.2026.e01032_bib40","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.etap.2013.04.007","article-title":"\u03b2-N-methylamino-l-alanine causes neurological and pathological phenotypes mimicking amyotrophic lateral sclerosis (ALS): the first step towards an experimental model for sporadic ALS","volume":"36","author":"de Munck","year":"2013","journal-title":"Environ Toxicol Pharmacol"},{"key":"10.1016\/j.neurot.2026.e01032_bib41","doi-asserted-by":"crossref","first-page":"20786","DOI":"10.1038\/s41598-021-00312-8","article-title":"Characteristics of serum metabolites in sporadic amyotrophic lateral sclerosis patients based on gas chromatography-mass spectrometry","volume":"11","author":"Jia","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.neurot.2026.e01032_bib42","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/6568","article-title":"Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis","volume":"5","author":"Klivenyi","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.neurot.2026.e01032_bib43","first-page":"CD005225","article-title":"Creatine for amyotrophic lateral sclerosis\/motor neuron disease","volume":"12","author":"Pastula","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.neurot.2026.e01032_bib44","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199205283262204","article-title":"Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis","volume":"326","author":"Rothstein","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurot.2026.e01032_bib45","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.neurobiolaging.2010.04.012","article-title":"Lactate dyscrasia: a novel explanation for amyotrophic lateral sclerosis","volume":"33","author":"Vadakkadath Meethal","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurot.2026.e01032_bib46","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jns.2004.04.011","article-title":"Maintained regulation of polyamines in spinal cord from patients with amyotrophic lateral sclerosis","volume":"222","author":"Ekegren","year":"2004","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurot.2026.e01032_bib47","doi-asserted-by":"crossref","first-page":"S23906","DOI":"10.1117\/1.JBO.30.S2.S23906","article-title":"Optical imaging of metabolic dynamics in ALS under methionine regulation","volume":"30","author":"Hoang","year":"2025","journal-title":"J Biomed Opt"},{"key":"10.1016\/j.neurot.2026.e01032_bib48","first-page":"97","article-title":"Perturbational profiling of metabolites in patient fibroblasts implicates \u03b1-Aminoadipate as a potential biomarker for bipolar disorder","volume":"2","author":"Huang","year":"2016","journal-title":"Mol Neuropsychiatry"},{"key":"10.1016\/j.neurot.2026.e01032_bib49","first-page":"1219","article-title":"Alteration of gut microbial metabolites in the systemic circulation of patients with parkinson\u2019s disease","volume":"12","author":"Chen","year":"2022","journal-title":"J Park Dis"},{"key":"10.1016\/j.neurot.2026.e01032_bib50","first-page":"610","article-title":"Review: the bile acids urso- and tauroursodeoxycholic acid as neuroprotective therapies in retinal disease","volume":"25","author":"Daruich","year":"2019","journal-title":"Mol Vis"},{"key":"10.1016\/j.neurot.2026.e01032_bib51","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/nep3.70001","article-title":"The role of gut microbiota-derived metabolites in neuroinflammation","volume":"3","author":"Mu","year":"2025","journal-title":"Neuroprotection"},{"key":"10.1016\/j.neurot.2026.e01032_bib52","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s40168-023-01656-1","article-title":"Microbiota-indole 3-propionic acid-brain axis mediates abnormal synaptic pruning of hippocampal microglia and susceptibility to ASD in IUGR offspring","volume":"11","author":"Wang","year":"2023","journal-title":"Microbiome"},{"key":"10.1016\/j.neurot.2026.e01032_bib53","first-page":"422","article-title":"[model of cytosine-, thymine-containing olygodeoxyribonucleotide protonation in solution]","volume":"57","author":"Kudrev","year":"2012","journal-title":"Biofizika"},{"key":"10.1016\/j.neurot.2026.e01032_bib54","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.nbd.2015.05.002","article-title":"N-acetyl-L-tryptophan delays disease onset and extends survival in an amyotrophic lateral sclerosis transgenic mouse model","volume":"80","author":"Li","year":"2015","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neurot.2026.e01032_bib55","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-1-0716-0771-8_14","article-title":"Development of LNA gapmer oligonucleotide-based therapy for ALS\/FTD caused by the C9orf72 repeat expansion","volume":"2176","author":"Sathyaprakash","year":"2020","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.neurot.2026.e01032_bib56","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1002\/acn3.51194","article-title":"Promoting identification of amyotrophic lateral sclerosis based on label-free plasma spectroscopy","volume":"7","author":"Zhang","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.neurot.2026.e01032_bib57","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3390\/biomedicines10061307","article-title":"Metabolic profile and pathological alterations in the muscle of patients with early-stage amyotrophic lateral sclerosis","volume":"10","author":"Lanznaster","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.neurot.2026.e01032_bib58","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3390\/metabo9060113","article-title":"Cerebral vitamin B5 (D-Pantothenic acid) deficiency as a potential cause of metabolic perturbation and neurodegeneration in huntington\u2019s disease","volume":"9","author":"Patassini","year":"2019","journal-title":"Metabolites"},{"key":"10.1016\/j.neurot.2026.e01032_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2022.110616","article-title":"Hypometabolic and hypermetabolic brain regions in patients with ALS-FTD show distinct patterns of grey and white matter degeneration: a pilot multimodal neuroimaging study","volume":"158","author":"Rajagopalan","year":"2023","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.neurot.2026.e01032_bib60","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.3390\/ijms23063188","article-title":"Uric acid and oxidative stress-relationship with cardiovascular, metabolic, and renal impairment","volume":"23","author":"Gherghina","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurot.2026.e01032_bib61","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1210\/js.2018-00106","article-title":"PAPPA2 as a therapeutic modulator of IGF-I bioavailability: in vivo and in vitro evidence","volume":"2","author":"Andrew","year":"2018","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.neurot.2026.e01032_bib62","doi-asserted-by":"crossref","first-page":"156355","DOI":"10.1016\/j.metabol.2025.156355","article-title":"Alteration of IGF-1 bioavailability due to PAPPA2 deficiency leads to sex-specific metabolic disturbances","volume":"171","author":"L\u00f3pez-Gambero","year":"2025","journal-title":"Metabolism"},{"key":"10.1016\/j.neurot.2026.e01032_bib63","first-page":"63","article-title":"Insulin-like growth factor-I for the treatment of amyotrophic lateral sclerosis","volume":"10","author":"Sakowski","year":"2009","journal-title":"Amyotroph Lateral Scler Off Publ World Fed Neurol Res Group Mot Neuron Dis"},{"key":"10.1016\/j.neurot.2026.e01032_bib64","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/hmg\/ddad188","article-title":"Clinical features, functional consequences, and rescue pharmacology of missense GRID1 and GRID2 human variants","volume":"33","author":"Allen","year":"2024","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurot.2026.e01032_bib65","doi-asserted-by":"crossref","first-page":"962321","DOI":"10.3389\/fmolb.2022.962321","article-title":"Functions of regulators of G protein signaling 16 in immunity, inflammation, and other diseases","volume":"9","author":"Tian","year":"2022","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.neurot.2026.e01032_bib66","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nature09884","article-title":"Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia","volume":"471","author":"Vacic","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neurot.2026.e01032_bib67","doi-asserted-by":"crossref","first-page":"104896","DOI":"10.1016\/j.neubiorev.2022.104896","article-title":"Protective role of IGF-1 and GLP-1 signaling activation in neurological dysfunctions","volume":"142","author":"Bhalla","year":"2022","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.neurot.2026.e01032_bib68","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fncel.2014.00061","article-title":"Trophic factors as modulators of motor neuron physiology and survival: implications for ALS therapy","volume":"8","author":"Tovar-Y-Romo","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.neurot.2026.e01032_bib69","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12964-024-01965-4","article-title":"Targeting uric acid: a promising intervention against oxidative stress and neuroinflammation in neurodegenerative diseases","volume":"23","author":"Xu","year":"2025","journal-title":"Cell Commun Signal CCS"},{"key":"10.1016\/j.neurot.2026.e01032_bib70","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1093\/brain\/awac394","article-title":"Neurofilament light chain in drug development for amyotrophic lateral sclerosis: a critical appraisal","volume":"146","author":"Benatar","year":"2023","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.neurot.2026.e01032_bib71","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fneur.2018.00039","article-title":"A possible role for platelet-activating factor receptor in amyotrophic lateral sclerosis treatment","volume":"9","author":"Briones","year":"2018","journal-title":"Front Neurol"},{"key":"10.1016\/j.neurot.2026.e01032_bib72","doi-asserted-by":"crossref","first-page":"21837","DOI":"10.1038\/s41598-024-70822-8","article-title":"Location and function of TDP-43 in platelets, alterations in neurodegenerative diseases and arising considerations for current plasma biobank protocols","volume":"14","author":"Luthi-Carter","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.neurot.2026.e01032_bib73","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/nan.12408","article-title":"Age-associated changes in the blood-brain barrier: comparative studies in human and mouse","volume":"44","author":"Goodall","year":"2018","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.neurot.2026.e01032_bib74","series-title":"Sex-specific hypothalamic axis disruption in the rNLS8 mouse model of amyotrophic lateral sclerosis (ALS) 2025","author":"Benito-Casado","year":"20250723"},{"key":"10.1016\/j.neurot.2026.e01032_bib75","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.70204","article-title":"A longitudinal study of sex differences in a TDP-43 mouse model reveals STI1 regulation of TDP-43 proteinopathy and motor deficits","volume":"169","author":"Novikov","year":"2025","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurot.2026.e01032_bib76","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1021\/acs.jproteome.4c00990","article-title":"Sex-specific markers of neuroinflammation and neurodegeneration in the spinal cord proteome of the SOD1G93A mouse model of amyotrophic lateral sclerosis","volume":"24","author":"Koehn","year":"2025","journal-title":"J Proteome Res"},{"key":"10.1016\/j.neurot.2026.e01032_bib77","first-page":"17","article-title":"An ALS-associated mutation dysregulates microglia-derived extracellular microRNAs in a sex-specific manner","author":"Christoforidou","year":"2024","journal-title":"Dis Model Mech"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926002023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926002023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:07:51Z","timestamp":1790125671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747926002023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":77,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1878747926002023"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e01032","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intrabody B1 targeting TDP-43 modulates neuroinflammatory and metabolic pathways in a preclinical ALS model","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e01032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e01032"}}